Our studies demonstrated that I3C attenuates ARDS through the downregulation of Th17 RORγt +IL-17a+IL-22+ cells and the upregulation of Th22 IL-17a-IL-22+ lymphocytes. This evidence concerns the gene IL17A and acute respiratory distress syndrome.